Additionally, suppression of cardiac hypertrophy was demonstrated by decreased expression of the hypertrophic marker ANP (Fig. 2C) and the fibrosis-associated gene TGFβ3 (Fig. 2D). The gene discussed is NPPA; the disease is cardiac hypertrophy.